Dawn Owen, M.D., Ph.D.

Publications

  1. Mathew AS, Atenafu EG, Owen D, Maurino C, Brade A, Brierley J, Dinniwell R, Kim J, Cho C, Ringash J, Wong R, Cuneo K, Feng M, Lawrence TS, Dawson LA. Long term outcomes of stereotactic body radiation therapy for hepatocellular carcinoma without macrovascular invasion. Eur J Cancer. 2020 Jul; 134:41-51 Epub 2020 May 24
    View PubMed
  2. Razavian N, Laucis A, Sun Y, Spratt DE, Owen D, Schonewolf C, Uppal S, Maturen KE, Jolly S. Radiation-Induced Insufficiency Fractures after Pelvic Irradiation for Gynecologic Malignancies: A Systematic Review. Int J Radiat Oncol Biol Phys. 2020 May 19 [Epub ahead of print]
    View PubMed
  3. Mendiratta-Lala M, Masch W, Owen D, Aslam A, Maurino C, Devasia T, Schipper MJ, Parikh ND, Cuneo K, Lawrence TS, Davenport MS. Natural history of hepatocellular carcinoma after stereotactic body radiation therapy. Abdom Radiol (NY). 2020 Apr 18 [Epub ahead of print]
    View PubMed
  4. Siontis BL, McHugh JB, Roberts E, Zhao L, Thomas DG, Owen D, Baker LH, Biermann JS, Schuetze SM, Chugh R. Differential Outcomes and Biologic Markers of Radiation-Associated vs. Sporadic Osteosarcoma: A Single-Institution Experience. Front Oncol. 2019; 9:1523 Epub 2020 Jan 22
    View PubMed
  5. Paradis KC, Mayo CS, Owen D, Spratt DE, Hearn J, Rosen B, Kashani R, Moran J, Tatro DS, Beeler WH, Vineberg K, Smith DC, Matuszak MM. The Special Medical Physics Consult Process for Reirradiation Patients Advances in Radiation Oncology. 2019; 4(4):559–565.
  6. Beeler WH, Speth KA, Broderick MT, Jairath NK, Ballouz D, Gharzai LA, Jackson WC, Kim MM, Owen D, Szerlip NJ, Paradis KC, Spratt DE. Local Control and Toxicity of Multilevel Spine Stereotactic Body Radiotherapy. Neurosurgery. 2019 Sep 20 Epub 2019 Sept 20
    View PubMed
  7. Jackson WC, Suresh K, Maurino C, Feng M, Cuneo KC, Ten Haken RK, Lawrence TS, Schipper MJ, Owen D. A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy. Radiother Oncol. 2019 Aug 17 [Epub ahead of print]
    View PubMed
  8. Mikell JK, Majdalany BS, Owen D, Paradis KC, Dewaraja YK. Assessing Spatial Concordance Between Theranostic Pairs Using Phantom and Patient-Specific Acceptance Criteria: Application to (99m)Tc-MAA SPECT/(90)Y-Microsphere PET. Int J Radiat Oncol Biol Phys. 2019 Aug 1; 104 (5):1133-1140 Epub 2019 Apr 22
    View PubMed
  9. Cuneo KC, Devasia T, Sun Y, Schipper MJ, Karnak D, Davis MA, Owen D, Feng M, El Naqa I, Bazzi L, Ten Haken R, Lawrence TS. Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury. Transl Oncol. 2019 Jul; 12 (7):889-894 Epub 2019 May 09
    View PubMed
  10. Dewaraja YK, Devasia T, Kaza RK, Mikell JK, Owen D, Roberson PL, Schipper M. Prediction of tumor control in (90)Y radioembolization by logit models with PET/CT based dose metrics. J Nucl Med. 2019 May 30 [Epub ahead of print]
    View PubMed
  11. Arnett ALH, Mou B, Owen D, Park SS, Nelson K, Hallemeier CL, Sio T, Garces YI, Olivier KR, Merrell KW. Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC. Adv Radiat Oncol. 2019 Apr-Jun; 4 (2):422-428 Epub 2019 Jan 24
    View PubMed
  12. Kong FS, Li L, Wang W, Campbell J, Waller JL, Piert M, Gross M, Cheng M, Owen D, Stenmark M, Huang KC, Frey KA, Ten Haken RK, Lawrence TS. Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol. 2019 Mar; 132:241-249 Epub 2018 Oct 30
    View PubMed
  13. Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino C, Cuneo KC, Lawrence TS, Owen D. Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up. Int J Radiat Oncol Biol Phys. 2019 Jan 1; 103 (1):169-179 Epub 2018 Sept 10
    View PubMed
  14. Mikell JK, Kaza RK, Roberson PL, Younge KC, Srinivasa RN, Majdalany BS, Cuneo KC, Owen D, Devasia T, Schipper MJ, Dewaraja YK. Impact of (90)Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization. EJNMMI Phys. 2018 Nov 30; 5 (1):31
    View PubMed
  15. Mendiratta-Lala M, Gu E, Owen D, Cuneo KC, Bazzi L, Lawrence TS, Hussain HK, Davenport MS. Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Nov 15; 102 (4):1063-1069 Epub 2017 Aug 24
    View PubMed
  16. Hawkins PG, Tang M, Vineberg K, Young L, Kovach K, Lee C, Maturen KE, Uppal S, Owen D, Schipper MJ, Priscinadaro JI, Jolly S. A Framework for Evaluation and Mitigation of the Dosimetric Impact of Interfractional Organs at Risk Variation in Patients Treated with Interstitial High-dose Rate Brachytherapy for gynecologic malignancies Med Dosim. 2018; 44(3):239-244.
    View PubMed
  17. Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys. 2018 Oct; 45 (10):e811-e819 Epub 2018 Sept 19
    View PubMed
  18. Parikh ND, Marshall VD, Green M, Lawrence TS, Razumilava N, Owen D, Singal AG, Feng M. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare. J Med Imaging Radiat Oncol. 2018 Oct; 62 (5):673-681 Epub 2018 June 07
    View PubMed
  19. Allred JD, Niedbala J, Mikell JK, Owen D, Frey KA, Dewaraja YK. The value of (99m)Tc-MAA SPECT/CT for lung shunt estimation in (90)Y radioembolization: a phantom and patient study. EJNMMI Res. 2018 Jun 15; 8 (1):50 Epub 2018 June 15
    View PubMed
  20. Simeth J, Johansson A, Owen D, Cuneo K, Mierzwa M, Feng M, Lawrence TS, Cao Y. Quantification of liver function by linearization of a two-compartment model of gadoxetic acid uptake using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 2018 Jun; 31 (6):e3913 Epub 2018 Apr 19
    View PubMed
  21. Younge KC, Marsh RB, Owen D, Geng H, Xiao Y, Spratt DE, Foy J, Suresh K, Wu QJ, Yin FF, Ryu S, Matuszak MM. Improving Quality and Consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for Spine Radiosurgery via Knowledge-Based Planning. Int J Radiat Oncol Biol Phys. 2018 Mar 15; 100 (4):1067-1074 Epub 2018 Jan 04
    View PubMed
  22. Jackson WC, Tao Y, Mendiratta-Lala M, Bazzi L, Wahl DR, Schipper MJ, Feng M, Cuneo KC, Lawrence TS, Owen D. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys. 2018 Mar 15; 100 (4):950-958 Epub 2017 Dec 15
    View PubMed
  23. El Naqa I, Johansson A, Owen D, Cuneo K, Cao Y, Matuszak M, Bazzi L, Lawrence TS, Ten Haken RK. Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 Feb 1; 100 (2):335-343
    View PubMed
  24. Sapir E, Tao Y, Schipper MJ, Bazzi L, Novelli PM, Devlin P, Owen D, Cuneo KC, Lawrence TS, Parikh ND, Feng M. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 Jan 1; 100 (1):122-130 Epub 2017 Sept 14
    View PubMed
  25. Suresh K, Owen D, Bazzi L, Jackson W, Ten Haken RK, Cuneo K, Feng M, Lawrence TS, Schipper MJ. Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2018 Jan 1; 100 (1):131-137 Epub 2017 Sept 22
    View PubMed
  26. Foy JJ, Marsh R, Ten Haken RK, Younge KC, Schipper M, Sun Y, Owen D, Matuszak MM. An analysis of knowledge-based planning for stereotactic body radiation therapy of the spine. Pract Radiat Oncol. 2017 Sep - Oct; 7 (5):e355-e360 Epub 2017 Mar 02
    View PubMed
  27. Mayo CS, Yao J, Eisbruch A, Balter JM, Litzenberg DW, Matuszak MM, Kessler ML, Weyburn G, Anderson CJ, Owen D, Jackson WC, Haken RT. Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards. Adv Radiat Oncol. 2017 Jul-Sep; 2 (3):503-514 Epub 2017 Apr 27
    View PubMed
  28. Luo Y, El Naqa I, McShan DL, Ray D, Lohse I, Matuszak MM, Owen D, Jolly S, Lawrence TS, Kong FS, Ten Haken RK. Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis. Radiother Oncol. 2017 Apr; 123 (1):85-92 Epub 2017 Feb 22
    View PubMed
  29. Matuszak MM, Matrosic C, Jarema D, McShan DL, Stenmark MH, Owen D, Jolly S, Kong FS, Ten Haken RK. Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imaging. Adv Radiat Oncol. 2016 Oct-Dec; 1 (4):281-289 Epub 2016 Oct 29
    View PubMed
  30. Cazoulat G, Owen D, Matuszak MM, Balter JM, Brock KK. Biomechanical deformable image registration of longitudinal lung CT images using vessel information. Phys Med Biol. 2016 Jul 7; 61 (13):4826-39 Epub 2016 June 08
    View PubMed
  31. Matuszak MM, Hadley SW, Feng M, Hayman JA, Brock KK, Burger P, Owen D, Suresh K, Schipper M, Lawrence TS, Moran JM. Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Pract Radiat Oncol. 2016 Mar-Apr; 6 (2):e39-46 Epub 2015 Dec 30
    View PubMed
  32. Owen D, Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Adv Radiat Oncol. 2016 Jan-Mar; 1 (1):76-81 Epub 2015 Dec 19
    View PubMed
  33. Owen D, Mayo CS, Song L, Ahmed K, Laack NN, Olivier KR. Dosimetric Analysis of Varying Cord PRV in Spine SBRT and Correlation with Toxicity Advances in Radiation Oncology. 2015; 1(1):76-81.
    View PubMed
  34. Owen D, Iqbal F, Pollock BE, Link MJ, Stien K, Garces YI, Brown PD, Foote RL. Long-term follow-up of stereotactic radiosurgery for head and neck malignancies. Head Neck. 2015 Nov; 37 (11):1557-62 Epub 2014 Aug 01
    View PubMed
  35. Ritter TA, Owen D, Brooks CM, Stenmark MH. Treatment planning for SBRT using automated field delivery: A case study. Med Dosim. 2015 Spring; 40 (1):44-6 Epub 2014 Sept 16
    View PubMed
  36. Willatt J, Hannawa KK, Ruma JA, Frankel TL, Owen D, Barman PM. Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective. World J Hepatol. 2015 Feb 27; 7 (2):235-44
    View PubMed
  37. Owen D, Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015 Feb 18; 10:43
    View PubMed
  38. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):e143-e149. Epub 2013 Jun 29.
    View PubMed
  39. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4:376 Epub 2015 Jan 14
    View PubMed
  40. Owen D, Tyldesley S, Alexander C, Speers C, Truong P, Nichol A, Wai ES. Outcomes in patients treated with mastectomy for ductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013 Mar 1; 85 (3):e129-34 Epub 2012 Nov 27
    View PubMed
  41. Owen D, Matthews SG. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function in juvenile guinea pigs. J Neuroendocrinol. 2007 Mar; 19 (3):172-80
    View PubMed
  42. Owen D, Matthews SG. Repeated maternal glucocorticoid treatment affects activity and hippocampal NMDA receptor expression in juvenile guinea pigs. J Physiol. 2007 Jan 1; 578 (Pt 1):249-57 Epub 2006 Oct 26
    View PubMed
  43. Owen D, Andrews MH, Matthews SG. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour. Neurosci Biobehav Rev. 2005 Apr; 29 (2):209-26
    View PubMed
  44. Owen D, Banjanin S, Gidrewicz D, McCabe L, Matthews SG. Central regulation of the hypothalamic-pituitary-adrenal axis during fetal development in the Guinea-pig. J Neuroendocrinol. 2005 Apr; 17 (4):220-6
    View PubMed
  45. Matthews SG, Owen D, Kalabis G, Banjanin S, Setiawan EB, Dunn EA, Andrews MH. Fetal glucocorticoid exposure and hypothalamo-pituitary-adrenal (HPA) function after birth. Endocr Res. 2004 Nov; 30 (4):827-36
    View PubMed
  46. Owen D, Setiawan E, Li A, McCabe L, Matthews SG. Regulation of N-methyl-D-aspartate receptor subunit expression in the fetal guinea pig brain. Biol Reprod. 2004 Aug; 71 (2):676-83 Epub 2004 Apr 28
    View PubMed
  47. Setiawan E, Owen D, McCabe L, Kostaki A, Andrews MH, Matthews SG. Glucocorticoids do not alter developmental expression of hippocampal or pituitary steroid receptor coactivator-1 and -2 in the late gestation fetal guinea pig. Endocrinology. 2004 Aug; 145 (8):3796-803 Epub 2004 May 06
    View PubMed
  48. Andrews MH, Kostaki A, Setiawan E, McCabe L, Owen D, Banjanin S, Matthews SG. Developmental regulation of the 5-HT7 serotonin receptor and transcription factor NGFI-A in the fetal guinea-pig limbic system: influence of GCs. J Physiol. 2004 Mar 16; 555 (Pt 3):659-70 Epub 2004 Jan 14
    View PubMed
  49. Owen D, Matthews SG. Glucocorticoids and sex-dependent development of brain glucocorticoid and mineralocorticoid receptors. Endocrinology. 2003 Jul; 144 (7):2775-84
    View PubMed
  50. Matthews SG, Owen D, Banjanin S, Andrews MH. Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Res. 2002 Nov; 28 (4):709-18
    View PubMed
  51. Owen D. From the womb to adulthood: programming glucocorticoid and mineralocorticoid receptor expression in the brain. Clin Invest Med. 2002 Jun; 25 (3):97-101
    View PubMed
PST-20472254